Man Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.79M Sell
239,263
-21,038
-8% -$676K 0.02% 926
2025
Q4
$9.16M Buy
260,301
+250,762
+2,629% +$8.89M 0.02% 838
2025
Q3
$251K Sell
9,539
-10,940
-53% -$326K ﹤0.01% 2060
2025
Q2
$543K Sell
20,479
-6,572
-24% -$173K ﹤0.01% 1805
2025
Q1
$653K Sell
27,051
-421,681
-94% -$13.3M ﹤0.01% 1700
2024
Q4
$18.1M Buy
448,732
+435,813
+3,373% +$24.9M 0.05% 466
2024
Q3
$818K Sell
12,919
-13,820
-52% -$811K ﹤0.01% 1546
2024
Q2
$1.42M Buy
+26,739
New +$1.75M ﹤0.01% 1444
2023
Q2
Hold
0
-$195K 2242
2023
Q1
Sell
-14,953
Closed -$154K 1807
2022
Q4
$141K Sell
14,953
-167,730
-92% -$749K ﹤0.01% 1843
2022
Q3
$497K Buy
+182,683
New +$598K ﹤0.01% 1522
2022
Q2
Sell
-12,400
Closed -$30.7K 1508
2022
Q1
$37K Buy
+12,400
New +$44.5K ﹤0.01% 2134
2018
Q4
Sell
-12,087
Closed -$211K 2128
2018
Q3
$211K Buy
+12,087
New +$144K ﹤0.01% 2014

Other funds holding VKTX